This article has been updated to correct an error in the headline.
 
NEW YORK (GenomeWeb News) - JPT Peptide Technologies, a subsidiary of Berlin-based pharmaceutical company Jerini, said today that Mount Sinai School of Medicine will use its PepStar peptide-microarray platform as part of a biomarker discovery collaboration.
 
JPT and MSSM will use the peptide arrays to discover B-cell epitopes for use in developing vaccines and diagnostics in the field of food allergies.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.